Bank of China Limited (SHA:601988)

Orchard Therapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	626,928	2,079,180	2,269,084	1,902,642	1,830,770	1,449,138
Investment Securities	9,561,390	8,763,251	7,596,063	6,774,905	6,411,933	5,892,353
Trading Asset Securities	778,650	738,054	657,701	717,125	627,525	650,066
Total Investments	10,340,040	9,501,305	8,253,764	7,492,030	7,039,458	6,542,419
Gross Loans	22,608,748	21,543,585	19,907,987	17,505,793	15,674,994	14,183,385
Allowance for Loan Losses	-556,309	-538,786	-484,908	-436,756	-390,090	-368,173
Net Loans	22,052,439	21,004,799	19,423,079	17,069,037	15,284,904	13,815,212
Property, Plant & Equipment	244,736	264,102	266,439	266,098	266,412	271,444
Goodwill	-	2,828	2,685	2,651	2,481	2,525
Other Intangible Assets	-	29,181	26,415	24,806	23,052	22,140
Investments in Real Estate	22,170	22,431	22,704	23,311	19,554	22,065
Accrued Interest Receivable	-	53,563	56,378	48,797	38,536	35,086
Other Receivables	-	243,654	182,787	226,238	377,134	490,926
Restricted Cash	2,305,631	1,546,954	1,668,454	1,551,359	1,478,465	1,442,384
Other Current Assets	105,288	179,635	96,968	130,215	276,258	223,313
Long-Term Deferred Tax Assets	67,405	62,691	75,156	71,139	51,172	58,916
Other Real Estate Owned & Foreclosed	-	2,177	3,152	2,153	2,043	2,120
Other Long-Term Assets	222,510	65,392	81,545	79,647	28,840	21,756
Total Assets	35,987,147	35,061,299	32,432,166	28,893,548	26,722,408	24,402,659
Accrued Expenses	-	56,960	52,117	46,657	39,655	34,143
Interest Bearing Deposits	25,610,499	23,844,817	22,602,835	19,940,140	17,920,168	16,944,904
Total Deposits	25,610,499	23,844,817	22,602,835	19,940,140	17,920,168	16,944,904
Short-Term Borrowings	124,568	2,877,497	2,202,024	2,307,387	2,563,959	2,118,394
Current Portion of Long-Term Debt	-	2,998,443	2,821,059	2,309,108	2,368,049	1,126,064
Current Portion of Leases	-	6,791	6,585	6,257	5,927	6,369
Current Income Taxes Payable	21,046	29,021	59,303	58,957	45,006	55,665
Accrued Interest Payable	-	357,771	304,215	261,685	222,719	191,986
Other Current Liabilities	55,363	257,112	118,533	121,743	80,687	96,852
Long-Term Debt	6,376,339	1,029,995	907,171	707,699	618,238	1,197,075
Long-Term Leases	-	11,925	12,212	13,364	13,692	15,524
Long-Term Unearned Revenue	-	7,080	6,865	6,579	6,362	11,532
Pension & Post-Retirement Benefits	1,565	1,594	1,676	1,842	2,095	2,199
Long-Term Deferred Tax Liabilities	9,546	9,130	7,397	6,804	7,003	6,499
Other Long-Term Liabilities	820,488	620,199	573,359	542,025	478,295	432,616
Total Liabilities	33,019,414	32,108,335	29,675,351	26,330,247	24,371,855	22,239,822
Preferred Stock, Convertible	99,969	119,550	119,550	119,550	119,550	147,519
Common Stock	294,388	294,388	294,388	294,388	294,388	294,388
Additional Paid-In Capital	-	133,620	133,632	133,634	133,648	133,679
Retained Earnings	1,935,566	1,881,294	1,765,162	1,618,816	1,474,126	1,326,267
Treasury Stock	-	-	-	-	-	-8
Comprehensive Income & Other	496,420	387,379	316,778	257,585	203,441	136,574
Total Common Equity	2,726,374	2,696,681	2,509,960	2,304,423	2,105,603	1,890,900
Minority Interest	141,390	136,733	127,305	139,328	125,400	124,418
Shareholders' Equity	2,967,733	2,952,964	2,756,815	2,563,301	2,350,553	2,162,837
Total Liabilities & Equity	35,987,147	35,061,299	32,432,166	28,893,548	26,722,408	24,402,659
Total Debt	6,500,907	6,924,651	5,949,051	5,343,815	5,569,865	4,463,426
Net Cash (Debt)	-3,908,842	-3,407,943	-2,316,695	-2,054,096	-2,544,066	-1,786,774
Net Cash Per Share	-13.38	-11.58	-7.87	-6.98	-8.64	-6.07
Filing Date Shares Outstanding	294,388	294,388	294,388	294,388	294,388	294,384
Total Common Shares Outstanding	294,388	294,388	294,388	294,388	294,388	294,384
Book Value Per Share	8.28	8.18	7.58	6.98	6.47	5.98
Tangible Book Value	2,726,374	2,664,672	2,480,860	2,276,966	2,080,070	1,866,235
Tangible Book Value Per Share	8.28	8.07	7.48	6.89	6.39	5.90

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Banks template. Financial Sources.